BSE Live
Mar 16, 12:43Prev. Close
370.10
Open Price
369.40
Bid Price (Qty.)
362.90 (10)
Offer Price (Qty.)
363.95 (4)
NSE Live
Mar 16, 12:43Prev. Close
368.75
Open Price
370.00
Bid Price (Qty.)
363.35 (9)
Offer Price (Qty.)
363.75 (27)
| Balance Sheet of SMS Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 8.87 | 8.47 | 8.47 | 8.47 | 8.47 | |
| Total Share Capital | 8.87 | 8.47 | 8.47 | 8.47 | 8.47 | |
| Reserves and Surplus | 648.33 | 533.45 | 486.63 | 485.30 | 419.76 | |
| Total Reserves and Surplus | 648.33 | 533.45 | 486.63 | 485.30 | 419.76 | |
| Total Shareholders Funds | 673.07 | 570.49 | 495.10 | 493.76 | 428.22 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 139.36 | 122.09 | 121.13 | 149.50 | 147.84 | |
| Deferred Tax Liabilities [Net] | 48.10 | 42.80 | 41.02 | 39.55 | 53.85 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.61 | 2.11 | 4.06 | |
| Long Term Provisions | 1.21 | 1.16 | 1.40 | 1.57 | 1.84 | |
| Total Non-Current Liabilities | 188.67 | 166.05 | 164.17 | 192.73 | 207.59 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 171.39 | 158.09 | 131.38 | 110.61 | 70.86 | |
| Trade Payables | 113.91 | 151.32 | 113.15 | 72.86 | 65.44 | |
| Other Current Liabilities | 37.95 | 21.27 | 9.34 | 11.99 | 56.97 | |
| Short Term Provisions | 1.11 | 1.03 | 1.04 | 1.02 | 0.82 | |
| Total Current Liabilities | 324.36 | 331.72 | 254.91 | 196.48 | 194.09 | |
| Total Capital And Liabilities | 1,186.10 | 1,068.25 | 914.18 | 882.97 | 829.91 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 530.85 | 434.60 | 410.55 | 436.62 | 455.76 | |
| Intangible Assets | 2.13 | 2.66 | 1.47 | 1.37 | 1.60 | |
| Capital Work-In-Progress | 34.67 | 30.27 | 33.19 | 11.00 | 6.74 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 567.65 | 467.53 | 445.21 | 449.00 | 464.11 | |
| Non-Current Investments | 45.11 | 45.10 | 45.10 | 45.00 | 45.00 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 15.94 | 19.04 | 13.23 | 11.93 | 11.47 | |
| Total Non-Current Assets | 628.70 | 531.67 | 503.54 | 505.92 | 520.58 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 284.73 | 233.70 | 223.50 | 251.10 | 137.79 | |
| Trade Receivables | 203.23 | 236.23 | 148.35 | 48.52 | 105.68 | |
| Cash And Cash Equivalents | 44.52 | 38.89 | 7.47 | 46.66 | 40.51 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OtherCurrentAssets | 24.92 | 27.76 | 31.33 | 30.77 | 25.35 | |
| Total Current Assets | 557.41 | 536.58 | 410.65 | 377.05 | 309.33 | |
| Total Assets | 1,186.10 | 1,068.25 | 914.18 | 882.97 | 829.91 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 21.45 | 49.91 | 132.30 | 138.21 | 65.97 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 93.43 | 105.54 | 126.09 | 103.48 | 50.91 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 2.40 | 4.14 | 0.52 | 0.18 | 22.66 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 6.87 | 0.17 | 0.44 | 0.55 | 2.10 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 312.68 | 302.46 | 316.50 | 126.67 | 135.93 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 2.42 | 2.42 | 2.42 | 2.42 | 2.42 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 45.11 | 45.10 | 45.10 | 45.00 | 45.00 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
18.02.2026
SMS Pharma Consolidated December 2025 Net Sales at Rs 210.45 crore, up 21.4% Y-o-Y
10.02.2026
SMS Pharma Standalone December 2025 Net Sales at Rs 210.45 crore, up 21.4% Y-o-Y
09.02.2026
05.01.2026
18.02.2026
SMS Pharma Consolidated December 2025 Net Sales at Rs 210.45 crore, up 21.4% Y-o-Y
10.02.2026
SMS Pharma Standalone December 2025 Net Sales at Rs 210.45 crore, up 21.4% Y-o-Y
14.11.2025
SMS Pharma Consolidated September 2025 Net Sales at Rs 242.43 crore, up 23.22% Y-o-Y
12.11.2025
SMS Pharma Standalone September 2025 Net Sales at Rs 242.43 crore, up 23.22% Y-o-Y
16.03.2026
15.03.2026
13.03.2026
13.03.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth